Table 3 Overall survival (in months) by demographic characteristics
Characteristic | n | Median | 95% CI | P -value |
|---|---|---|---|---|
Overall | 46 | 18.3 | 13.7, 25.9 | |
Age group | 0.44 | |||
<60 | 22 | 20.5 | 14.5, 31.4 | |
⩾60 | 24 | 14.7 | 9.5, 25.9 | |
Country | 0.21 | |||
France | 21 | 17.0 | 7.8, 25.9 | |
USA | 25 | 19.4 | 13.7, NA | |
Gender | 0.83 | |||
Female | 24 | 19.4 | 10.9, 30.7 | |
Male | 22 | 18.1 | 14.5, 25.9 | |
Ethnicity | 0.10 | |||
African descent | 3 | 13.7 | 4.4, 18.3 | |
Non African descent | 43 | 19.4 | 13.4, 26.4 | |
Performance status | 0.29 | |||
0 | 30 | 18.3 | 13.4, 25.9 | |
1–2 | 16 | 16.1 | 10.2, NA | |
Tumour size | 0.23 | |||
<3 cm | 15 | 16.1 | 10.9, 20.5 | |
⩾3 cm | 27 | 19.4 | 13.7, 45.7 | |
Nodal status | 0.15 | |||
Negative | 13 | 30.7 | 13.7, NA | |
Positive | 30 | 15.4 | 9.7, 20.5 | |
Stage | 0.07 | |||
T1,2 | 12 | 30.7 | 18.3, NA | |
T3,4 | 32 | 14.6 | 10.2, 20.9 |
